Abstract
Leptospira species are long, thin, motile spirochetes that are responsible for causing a biphasic illness known as leptospirosis. The first phase of disease is characterized by an acute, nonspecific febrile illness that can be followed by a second phase of immune-mediated complications. Moderate and severe infection from Leptospira species bacteria cause significant morbidity and mortality worldwide. The infection is especially prevalent among young men who reside in resource-poor tropical countries. Given the variable presentations of the disease, its high burden in countries with limited resources, and complexities associated with securing a definitive diagnosis, leptospirosis is vastly underreported. Management of the infection includes treatment with antibiotics along with varying degrees of supportive care to address a wide range of associated complications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Budihal SV. Leptospirosis diagnosis: competency of various laboratory tests. J Clin Diagn Res. 2014;8(1):199–202.
Butler T. The Jarisch–Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis. Am J Trop Med Hyg. 2016;96(1):46–52.
Clem A, Izurieta R, Galwankar S. Leptospirosis: the “mysterious” mimic. J Emerg Trauma Shock. 2008;1(1):21.
Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLOS Negl Trop Dis. 2015;9(9):e0003898.
Gulati S, Gulati A. Pulmonary manifestations of leptospirosis. Lung India. 2012;29(4):347.
Leptospirosis CW. Manson’s tropical infectious diseases. 23rd ed. Beijing: Elsevier Health Sciences; 2014. p. 433–40.
Leptospirosis [Internet]. Centers for Disease Control and Prevention; 2017a [cited 2017 Nov 28]. Available from: https://www.cdc.gov/leptospirosis/health_care_workers/index.html.
Leptospirosis [Internet]. Centers for Disease Control and Prevention; 2017b [cited 2017 Nov 28]. Available from: https://www.cdc.gov/leptospirosis/symptoms/index.html.
Leptospirosis Burden Epidemiology Reference Group (LERG) [Internet]. WHO. World Health Organization; [cited 2017 Nov 28]. Available from: http://www.who.int/zoonoses/diseases/lerg/en/index2.html.
Mwachui MA, Crump L, Hartskeerl R, Zinsstag J, Hattendorf J. Environmental and behavioural determinants of leptospirosis transmission: a systematic review. PLOS Negl Trop Dis. 2015;9(9):e0003843.
Organization WH. Human leptospirosis: : guidance for diagnosis, surveillance and control [Internet]. WHO. Geneva: World Health Organization; 1970 [cited 2017 Nov 28]. Available from: http://www.who.int/iris/handle/10665/42667.
Pavli A, Maltezou HC. Travel-acquired leptospirosis: table 37.1. J Travel Med. 2008;15(6):447–53.
Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global burden of leptospirosis: Estimated in terms of disability adjusted life years. PLOS Negl Trop Dis. 2015;9(10):e0004122.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Lichtenstein, D., Domachowske, J. (2019). Leptospirosis. In: Domachowske, J. (eds) Introduction to Clinical Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-91080-2_37
Download citation
DOI: https://doi.org/10.1007/978-3-319-91080-2_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91079-6
Online ISBN: 978-3-319-91080-2
eBook Packages: MedicineMedicine (R0)